Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8581 |
High Similarity |
NPD2532 |
Approved |
0.8581 |
High Similarity |
NPD2533 |
Approved |
0.8581 |
High Similarity |
NPD2534 |
Approved |
0.8212 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8176 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.8141 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.8121 |
Intermediate Similarity |
NPD2800 |
Approved |
0.8054 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.8025 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8012 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.8 |
Intermediate Similarity |
NPD3226 |
Approved |
0.8 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7975 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7973 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7949 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7947 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7901 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7901 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7879 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7867 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7857 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7838 |
Intermediate Similarity |
NPD1607 |
Approved |
0.78 |
Intermediate Similarity |
NPD2796 |
Approved |
0.78 |
Intermediate Similarity |
NPD6100 |
Approved |
0.78 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.78 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7799 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7778 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7756 |
Intermediate Similarity |
NPD920 |
Approved |
0.775 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7748 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7748 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7736 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7733 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7733 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7712 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7712 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7703 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7702 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7697 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7687 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7677 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7673 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.766 |
Intermediate Similarity |
NPD4626 |
Approved |
0.7658 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7654 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7628 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7625 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7605 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.76 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7597 |
Intermediate Similarity |
NPD7003 |
Approved |
0.7589 |
Intermediate Similarity |
NPD5691 |
Approved |
0.7589 |
Intermediate Similarity |
NPD1651 |
Approved |
0.758 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7578 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7576 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7568 |
Intermediate Similarity |
NPD1699 |
Clinical (unspecified phase) |
0.7564 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7547 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7546 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7543 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7535 |
Intermediate Similarity |
NPD3412 |
Clinical (unspecified phase) |
0.7531 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7529 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7517 |
Intermediate Similarity |
NPD6696 |
Suspended |
0.7517 |
Intermediate Similarity |
NPD1283 |
Approved |
0.7516 |
Intermediate Similarity |
NPD37 |
Approved |
0.7516 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7516 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.75 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.75 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.75 |
Intermediate Similarity |
NPD3972 |
Approved |
0.75 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.7485 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7485 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7485 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7485 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7469 |
Intermediate Similarity |
NPD5761 |
Phase 2 |
0.7469 |
Intermediate Similarity |
NPD5760 |
Phase 2 |
0.7467 |
Intermediate Similarity |
NPD2979 |
Phase 3 |
0.7452 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.745 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.745 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.745 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7439 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7429 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7419 |
Intermediate Similarity |
NPD1243 |
Approved |
0.741 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7403 |
Intermediate Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.7396 |
Intermediate Similarity |
NPD7177 |
Discontinued |
0.7394 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7389 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7386 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7384 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7381 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7381 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7381 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7381 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7378 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7372 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7362 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7358 |
Intermediate Similarity |
NPD6273 |
Approved |
0.7356 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7355 |
Intermediate Similarity |
NPD2424 |
Discontinued |
0.7353 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7347 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7347 |
Intermediate Similarity |
NPD1470 |
Approved |
0.7342 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7338 |
Intermediate Similarity |
NPD5405 |
Approved |
0.7338 |
Intermediate Similarity |
NPD5406 |
Approved |
0.7338 |
Intermediate Similarity |
NPD5408 |
Approved |
0.7338 |
Intermediate Similarity |
NPD5404 |
Approved |
0.7333 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7329 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7325 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7314 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7314 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7312 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.731 |
Intermediate Similarity |
NPD1281 |
Approved |
0.731 |
Intermediate Similarity |
NPD1201 |
Approved |
0.7308 |
Intermediate Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.7303 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7297 |
Intermediate Similarity |
NPD6917 |
Clinical (unspecified phase) |
0.7297 |
Intermediate Similarity |
NPD2798 |
Approved |
0.729 |
Intermediate Similarity |
NPD1471 |
Phase 3 |
0.729 |
Intermediate Similarity |
NPD6002 |
Phase 3 |
0.729 |
Intermediate Similarity |
NPD6004 |
Phase 3 |
0.729 |
Intermediate Similarity |
NPD6005 |
Phase 3 |
0.729 |
Intermediate Similarity |
NPD6003 |
Clinical (unspecified phase) |
0.729 |
Intermediate Similarity |
NPD6006 |
Clinical (unspecified phase) |
0.7289 |
Intermediate Similarity |
NPD919 |
Approved |
0.7279 |
Intermediate Similarity |
NPD1876 |
Approved |
0.7273 |
Intermediate Similarity |
NPD9545 |
Approved |
0.7266 |
Intermediate Similarity |
NPD1609 |
Clinical (unspecified phase) |
0.726 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7253 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7253 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7253 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7253 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7253 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7253 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7253 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7251 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7241 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7241 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7237 |
Intermediate Similarity |
NPD4307 |
Phase 2 |
0.7226 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7226 |
Intermediate Similarity |
NPD2438 |
Suspended |
0.7219 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7212 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7209 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7209 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7202 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7193 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.719 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.719 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7188 |
Intermediate Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.7172 |
Intermediate Similarity |
NPD2932 |
Approved |
0.7172 |
Intermediate Similarity |
NPD1778 |
Approved |
0.7168 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7163 |
Intermediate Similarity |
NPD1241 |
Discontinued |
0.7151 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7143 |
Intermediate Similarity |
NPD4097 |
Suspended |
0.7135 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7135 |
Intermediate Similarity |
NPD7698 |
Approved |
0.7135 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.7135 |
Intermediate Similarity |
NPD7697 |
Approved |
0.7133 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7133 |
Intermediate Similarity |
NPD9494 |
Approved |
0.7126 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7124 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7118 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7118 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7115 |
Intermediate Similarity |
NPD2531 |
Phase 2 |
0.7115 |
Intermediate Similarity |
NPD4477 |
Approved |
0.7115 |
Intermediate Similarity |
NPD4476 |
Approved |
0.7114 |
Intermediate Similarity |
NPD3267 |
Approved |
0.7114 |
Intermediate Similarity |
NPD3266 |
Approved |
0.7108 |
Intermediate Similarity |
NPD4288 |
Approved |
0.7105 |
Intermediate Similarity |
NPD411 |
Approved |
0.7097 |
Intermediate Similarity |
NPD7870 |
Phase 2 |
0.7097 |
Intermediate Similarity |
NPD7871 |
Phase 2 |
0.7095 |
Intermediate Similarity |
NPD3600 |
Clinical (unspecified phase) |
0.7093 |
Intermediate Similarity |
NPD7893 |
Clinical (unspecified phase) |
0.7093 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7089 |
Intermediate Similarity |
NPD2654 |
Approved |
0.7086 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7086 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7086 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7078 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7076 |
Intermediate Similarity |
NPD2403 |
Approved |
0.7073 |
Intermediate Similarity |
NPD7028 |
Phase 2 |
0.7069 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7069 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7059 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7059 |
Intermediate Similarity |
NPD8032 |
Phase 2 |
0.7055 |
Intermediate Similarity |
NPD3019 |
Approved |
0.7055 |
Intermediate Similarity |
NPD17 |
Approved |
0.7051
|
Intermediate Similarity |
NPD3299 |
Clinical (unspecified phase) |